| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/08/2013 | CN202920659U Waterproof breathable medicament plaster |
| 05/08/2013 | CN202920448U Neck hot compress bag |
| 05/08/2013 | CN103097365A 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (S1P) receptors |
| 05/08/2013 | CN103097353A Novel immunomodulator and anti inflammatory compounds |
| 05/08/2013 | CN103096907A Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
| 05/08/2013 | CN103096904A Mitigating agent for alcohol-induced problems |
| 05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
| 05/08/2013 | CN103087192A Anti-KDR antibodies and methods of use |
| 05/08/2013 | CN103087153A New neovessel inhibition small peptides and applications thereof |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087026A Crystal form D of 7-hydroxyl isoflavone, preparation method of crystal form D and medicine composition and use of crystal form D |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103086943A Indoles derivative functioning as CRTH2 receptor antagonist |
| 05/08/2013 | CN103086923A Hydrazine cathepsin K inhibitor and application thereof in treating osteoporosis |
| 05/08/2013 | CN103086863A Alkannin dimer compounds and uses of the same in drug preparation |
| 05/08/2013 | CN103083740A Method for treating joint disease and skin disease by utilizing Chinese medicine acupuncture and cupping technology |
| 05/08/2013 | CN103083678A Method for modifying uricase by active polyethylene glycol (PEG) against amino group under protection of competitive inhibitor |
| 05/08/2013 | CN103083672A DPP-IV inhibitor combined with further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 05/08/2013 | CN103083670A Application of inhibiting agent of cathepsin K |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083650A Composition with bone mineral density addition function, and preparation method as well as application of composition |
| 05/08/2013 | CN103083648A Troche for enhancing bone mineral density based on milk mineral salt as raw material as well as preparation method thereof |
| 05/08/2013 | CN103083639A Medicament for treating postpartum pain of body |
| 05/08/2013 | CN103083638A Medicament for treating osteoporosis |
| 05/08/2013 | CN103083637A Pharmaceutical composition for treating rheumatism |
| 05/08/2013 | CN103083630A Plaster for treating osteoproliferation |
| 05/08/2013 | CN103083629A Medicine composition for treating cervical vertebra hyperostosis and preparation method thereof |
| 05/08/2013 | CN103083621A Medical composition for treating osteoarthritis |
| 05/08/2013 | CN103083609A Traditional Chinese medicine for treating cervical spondylosis, lumbar intervertebral disc herniation and ankylosing spondylitis |
| 05/08/2013 | CN103083602A Externally used pharmaceutical composition for treating lumbar disease |
| 05/08/2013 | CN103083598A Chinese patent medicine for treating chronic osteomyelitis |
| 05/08/2013 | CN103083592A Traditional Chinese medicine for treating gouty arthritis |
| 05/08/2013 | CN103083591A Traditional Chinese medicine decoction for treating suppurative gonarthritis |
| 05/08/2013 | CN103083578A Drug for treating rheumatic arthritis |
| 05/08/2013 | CN103083556A Traditional Chinese medicine for treating cervical spondylosis |
| 05/08/2013 | CN103083521A Extraction method, separated extract and preparation of Xianlinggubao |
| 05/08/2013 | CN103083515A Traditional Chinese medicine preparation used for treating arthralgia, and preparation method thereof |
| 05/08/2013 | CN103083513A Method for preparing high-purity dioscorea nipponica makino total saponin |
| 05/08/2013 | CN103083497A External preparation traditional Chinese medicine for treating hyperosteogeny and preparation method thereof |
| 05/08/2013 | CN103083489A Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds |
| 05/08/2013 | CN103083488A Traditional Chinese medical composition for treating bone disease as well as preparation thereof |
| 05/08/2013 | CN103083487A pharmaceutical composition for invigorating blood circulation and alleviating pain and preparation method thereof |
| 05/08/2013 | CN103083485A Externally applied agent for treating heel spur |
| 05/08/2013 | CN103083479A Traditional Chinese medical composition for treating postmenopausal osteoporosis |
| 05/08/2013 | CN103083475A Preparation method for pyogenic osteomyelitis treatment traditional Chinese medicine preparation |
| 05/08/2013 | CN103083464A Traditional Chinese medical liquid for treating osteoproliferation |
| 05/08/2013 | CN103083458A Warm light drink compound formula granule, as well as preparation method as well as detection method thereof |
| 05/08/2013 | CN103083443A Chinese medicinal composition for treating arthritis and preparation method thereof |
| 05/08/2013 | CN103083426A Traditional Chinese medicine for treating osteoarthritis and preparation method thereof |
| 05/08/2013 | CN103083419A Application of clematis root total saponins in preparing medicines inhibiting hyperuricemia and gout |
| 05/08/2013 | CN103083407A Traditional Chinese medicine composition for treating osteomyelitis |
| 05/08/2013 | CN103083378A Chinese medicinal composition for treating hyperosteogeny and preparation method thereof |
| 05/08/2013 | CN103083377A Giant salamander bone calcium tablet and preparation method thereof |
| 05/08/2013 | CN103083371A Medicine composition for treating infant chondropathy and preparation method thereof |
| 05/08/2013 | CN103083342A Application of flavan compound in preparing anti-complement medicines |
| 05/08/2013 | CN103083314A Compound ibuprofen having gastrointestinal protective effect |
| 05/08/2013 | CN103083271A Analgesic tablet for pets |
| 05/08/2013 | CN103083235A Myricetin nanosuspension and preparation method thereof |
| 05/08/2013 | CN103082276A Composition for reducing sport injury and promoting sport injury repair |
| 05/08/2013 | CN102586063B Middle-aged health care wine |
| 05/08/2013 | CN102430005B Traditional Chinese medicinal honeyed pill for treating bone fracture |
| 05/08/2013 | CN102406766B Traditional Chinese medicine composition for treating bone fracture and application thereof |
| 05/08/2013 | CN102397550B Medicinal composition composed of aspirin and estrogen and used for preventing and treating osteoporosis |
| 05/08/2013 | CN102370836B External application traditional Chinese medicine for treating traumatic synovitis |
| 05/08/2013 | CN102327216B Limaprost nanoemulsion preparation for vertebral canal injection of antisternum |
| 05/08/2013 | CN102258591B Dampness eliminating, arthralgia relieving and meridian activating capsules |
| 05/08/2013 | CN101821236B Five-membered heterocyclic compound |
| 05/08/2013 | CN101712964B Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof |
| 05/08/2013 | CN101560546B Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
| 05/07/2013 | US8435987 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/07/2013 | US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 05/07/2013 | US8435946 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 05/07/2013 | US8435552 Collagen/hydroxyapatite composite scaffold, and process for the production thereof |
| 05/07/2013 | CA2647988C Interleukin production regulator, pharmaceutical composition, food, and drink containing interleukin production regulator, and production method thereof |
| 05/02/2013 | WO2013063095A1 Immunobinders directed against sclerostin |
| 05/02/2013 | WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
| 05/02/2013 | WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
| 05/02/2013 | WO2013061004A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
| 05/02/2013 | WO2013060303A1 Polypeptides inhibiting neovascularization and uses thereof |
| 05/02/2013 | WO2013060179A1 Acyltetrahydro-β-carboline compounds as well as derivatives, applications and preparation methods thereof |
| 05/02/2013 | WO2013060005A1 Method for detecting specific single nucleotide polymorphism related to ankylosing spondylitis and kit therefor |
| 05/02/2013 | WO2013060004A1 Method for detecting specific single nucleotide polymorphism related to ankylosing spondylitis and kit therefor |
| 05/02/2013 | US20130109665 Novel pyrazine derivatives |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |
| 05/02/2013 | US20130108666 Glass/carbon nanotube composite material for bone graft support |
| 05/02/2013 | US20130108619 Intravenous immunoglobulin processing, diagnostic, and treatment systems and methods |
| 05/02/2013 | US20130108578 Apo-2 ligand variants and uses thereof |
| 05/02/2013 | CA2853732A1 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture |
| 05/02/2013 | CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative |
| 05/02/2013 | CA2853258A1 Immunobinders directed against sclerostin |
| 05/02/2013 | CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
| 05/02/2013 | CA2848263A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
| 05/01/2013 | EP2586442A1 Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 05/01/2013 | EP2585445A2 Polymorphs of an active pharmaceutical ingredient |
| 05/01/2013 | EP2585437A2 Thioacetate compounds, compositions and methods of use |
| 05/01/2013 | EP2585083A1 A method for preparing a bone protein preparation and a bone protein preparation |
| 05/01/2013 | EP2584913A1 Stabilized active compound |
| 05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |